Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Etoposide poisoning |
Causative agent |
True |
Etoposide (substance) |
Inferred relationship |
Some |
1 |
Accidental etoposide poisoning |
Causative agent |
False |
Etoposide (substance) |
Inferred relationship |
Some |
|
Intentional etoposide poisoning |
Causative agent |
False |
Etoposide (substance) |
Inferred relationship |
Some |
|
forgiftning med etoposid, uvist med hvilken hensigt |
Causative agent |
False |
Etoposide (substance) |
Inferred relationship |
Some |
1 |
Etoposide adverse reaction |
Causative agent |
True |
Etoposide (substance) |
Inferred relationship |
Some |
1 |
Allergy to etoposide |
Causative agent |
False |
Etoposide (substance) |
Inferred relationship |
Some |
|
Etoposide overdose |
Causative agent |
True |
Etoposide (substance) |
Inferred relationship |
Some |
1 |
Accidental etoposide overdose |
Causative agent |
True |
Etoposide (substance) |
Inferred relationship |
Some |
1 |
Intentional etoposide overdose |
Causative agent |
True |
Etoposide (substance) |
Inferred relationship |
Some |
1 |
overdosis af etoposid, uvist med hvilken hensigt |
Causative agent |
False |
Etoposide (substance) |
Inferred relationship |
Some |
1 |
Etoposide 50 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Etoposide (substance) |
Inferred relationship |
Some |
|
Etoposide 100 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Etoposide (substance) |
Inferred relationship |
Some |
|
Etoposide 100mg/5mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Etoposide (substance) |
Inferred relationship |
Some |
|
Etoposide 100mg/vial injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Etoposide (substance) |
Inferred relationship |
Some |
|
Etoposide phosphate 100mg/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Etoposide (substance) |
Inferred relationship |
Some |
|
etoposid 20 mg koncentrat til infusionsvæske, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Etoposide (substance) |
Inferred relationship |
Some |
|
etoposid 20 mg koncentrat til infusionsvæske, hætteglas a 25 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Etoposide (substance) |
Inferred relationship |
Some |
|
etoposid 150 mg koncentrat til infusionsvæske, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Etoposide (substance) |
Inferred relationship |
Some |
|
etoposid 100 mg koncentrat til infusionsvæske, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Etoposide (substance) |
Inferred relationship |
Some |
|
etoposid 1 g koncentrat til infusionsvæske, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Etoposide (substance) |
Inferred relationship |
Some |
|
etoposid 500 mg koncentrat til infusionsvæske, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Etoposide (substance) |
Inferred relationship |
Some |
|
Etoposide 400mg/20mL injection concentrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Etoposide (substance) |
Inferred relationship |
Some |
|
Product containing etoposide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Etoposide (substance) |
Inferred relationship |
Some |
1 |
Vinca alkaloids and etoposide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Etoposide (substance) |
Inferred relationship |
Some |
|
Etoposide 100mg/5mL powder for injection 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Etoposide (substance) |
Inferred relationship |
Some |
|
Etoposide 100mg/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Etoposide (substance) |
Inferred relationship |
Some |
|
etoposid 500 mg/25 ml infusionsvæske, koncentrat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Etoposide (substance) |
Inferred relationship |
Some |
|
etoposid 400 mg/20 ml koncentrat til infusionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Etoposide (substance) |
Inferred relationship |
Some |
|
Etoposide (as etoposide phosphate) 100 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Etoposide (substance) |
Inferred relationship |
Some |
|
etoposid 100 mg/5 ml infusionsvæske, koncentrat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Etoposide (substance) |
Inferred relationship |
Some |
|
Accidental etoposide poisoning |
Causative agent |
True |
Etoposide (substance) |
Inferred relationship |
Some |
1 |
Intentional etoposide poisoning |
Causative agent |
True |
Etoposide (substance) |
Inferred relationship |
Some |
1 |
Etoposide phosphate (substance) |
Is a |
False |
Etoposide (substance) |
Inferred relationship |
Some |
|
Allergy to etoposide |
Causative agent |
True |
Etoposide (substance) |
Inferred relationship |
Some |
1 |
Product containing etoposide in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Etoposide (substance) |
Inferred relationship |
Some |
1 |
Product containing etoposide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Etoposide (substance) |
Inferred relationship |
Some |
1 |
Rituximab, ifosfamide, carboplatin and etoposide chemotherapy regimen (regime/therapy) |
Direct substance |
True |
Etoposide (substance) |
Inferred relationship |
Some |
5 |
Etoposide 50 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Etoposide (substance) |
Inferred relationship |
Some |
1 |
Etoposide 50 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Etoposide (substance) |
Inferred relationship |
Some |
1 |
Etoposide 100 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Etoposide (substance) |
Inferred relationship |
Some |
1 |
Etoposide 100 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Etoposide (substance) |
Inferred relationship |
Some |
1 |
Etoposide phosphate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Etoposide (substance) |
Inferred relationship |
Some |
|
Etoposide 100mg/5mL conventional release solution for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Etoposide (substance) |
Inferred relationship |
Some |
|
Etoposide 100 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Etoposide (substance) |
Inferred relationship |
Some |
1 |
Etoposide 50 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Etoposide (substance) |
Inferred relationship |
Some |
1 |
Etoposide (as etoposide phosphate) 100 mg powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Etoposide (substance) |
Inferred relationship |
Some |
1 |
Etoposide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Etoposide (substance) |
Inferred relationship |
Some |
1 |
Product containing only etoposide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Etoposide (substance) |
Inferred relationship |
Some |
1 |
Etoposide only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Etoposide (substance) |
Inferred relationship |
Some |
1 |
R-CEOP (rituximab, cyclophosphamide, etoposide, vincristine, prednisone) antineoplastic chemotherapy |
Direct substance |
True |
Etoposide (substance) |
Inferred relationship |
Some |
4 |
Product containing precisely etoposide 20 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Etoposide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely etoposide 20 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Etoposide (substance) |
Inferred relationship |
Some |
1 |